Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells

[1]  A. Scorilas,et al.  Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  A. Scorilas,et al.  Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers , 2013, Medical Oncology.

[3]  A. Scorilas,et al.  Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells. , 2012, Gene.

[4]  R. Mahdian,et al.  Nonsense mediated decay of VWF mRNA subsequent to c.7674-7675insC mutation in type3 VWD patients. , 2012, Blood cells, molecules & diseases.

[5]  A. Scorilas,et al.  The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. , 2011, The oncologist.

[6]  A. Scorilas,et al.  BCL2L12 is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma , 2011, Molecular medicine.

[7]  L. Chin,et al.  Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. , 2010, Genes & development.

[8]  S. Mello,et al.  Alterations in gene expression profiles correlated with cisplatin cytotoxicity in the glioma U343 cell line , 2010, Genetics and molecular biology.

[9]  A. Scorilas,et al.  Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. , 2010, Biochemical and biophysical research communications.

[10]  A. Scorilas,et al.  Molecular Response of HL‐60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis‐Related Gene Expressions, Including the New Member BCL2L12 , 2009, Annals of the New York Academy of Sciences.

[11]  A. Scorilas,et al.  Treatment of Gastric Cancer Cells with 5-Fluorouracil/Leucovorin and Irinotecan Induces Distinct Alterations in the mRNA Expression of the Apoptosis-Related Genes, Including the Novel Gene BCL2L12 , 2009, Tumor Biology.

[12]  A. Argyriou,et al.  Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. , 2009, Critical reviews in oncology/hematology.

[13]  C. Scrideli,et al.  Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR , 2009, BMC Molecular Biology.

[14]  A. Scorilas,et al.  Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer , 2008, Biological chemistry.

[15]  Si Zhang,et al.  Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells. , 2008, Biochimica et biophysica acta.

[16]  A. Scorilas,et al.  Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol , 2008, Biological chemistry.

[17]  W. Xu,et al.  [Inducing-apoptosis effect of bortezomib on acute monocytic leukemia cell SHI-1 and its influence on expressions of Bcl2l12, Bcl-2 and Bax genes]. , 2008, Zhongguo shi yan xue ye xue za zhi.

[18]  L. Chin,et al.  What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator , 2008, Cell cycle.

[19]  L. Chin,et al.  Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma , 2008, Proceedings of the National Academy of Sciences.

[20]  A. Foster,et al.  Quantitative real-time RT-PCR measurement of cytokine mRNA expression in the skin of normal cats and cats with allergic skin disease. , 2008, Veterinary immunology and immunopathology.

[21]  Zhaohui Gong,et al.  The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells , 2008, In Vitro Cellular & Developmental Biology - Animal.

[22]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[23]  N. Seki,et al.  Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line. , 2007, Anticancer research.

[24]  K. Nugent,et al.  Cisplatin Nephrotoxicity: A Review , 2007, The American journal of the medical sciences.

[25]  Andreas Scorilas,et al.  Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. , 2007, Cancer letters.

[26]  A. Scorilas,et al.  Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis‐Related Genes, Including the New Member, BCL2L12 , 2007, Annals of the New York Academy of Sciences.

[27]  L. Chin,et al.  Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. , 2007, Genes & development.

[28]  A. Scorilas,et al.  Alterations in mRNA Expression of Apoptosis‐Related Genes BCL2, BAX, FAS, Caspase‐3, and the Novel Member BCL2L12 after Treatment of Human Leukemic Cell Line HL60 with the Antineoplastic Agent Etoposide , 2006, Annals of the New York Academy of Sciences.

[29]  A. Scorilas,et al.  Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS , 2006, Biological chemistry.

[30]  E. Yang,et al.  BCL2 family in DNA damage and cell cycle control , 2006, Cell Death and Differentiation.

[31]  P. Krzyzanowski,et al.  Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling , 2006, Oncogene.

[32]  A. Scorilas,et al.  Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells , 2006, Biological chemistry.

[33]  T. Boulikas,et al.  Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). , 2004, Oncology reports.

[34]  A. Scorilas,et al.  Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer , 2004, Biological chemistry.

[35]  A. Scorilas,et al.  Cisplatin‐Induced Apoptosis in HL‐60 Human Promyelocytic Leukemia Cells , 2003, Annals of the New York Academy of Sciences.

[36]  Raymond Sawaya,et al.  Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis , 2002, Neurosurgery.

[37]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[38]  José Perez,et al.  Is cisplatin-induced cell death always produced by apoptosis? , 2001, Molecular pharmacology.

[39]  L. Ashworth,et al.  Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. , 2001, Genomics.

[40]  P. Jordan,et al.  Molecular mechanisms involved in cisplatin cytotoxicity , 2000, Cellular and Molecular Life Sciences CMLS.

[41]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[42]  A. Rahmouni,et al.  Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  U. Hübscher,et al.  Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eucaryotic DNA polymerases alpha. , 1988, Nucleic acids research.

[44]  S. Lippard,et al.  Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). , 1985, Proceedings of the National Academy of Sciences of the United States of America.